Patent EP2303272A1 – Sofinicline (abt-894 ) for attention-deficit/hyperactivity disorder – Google Patents

3- (5, 6-Dichloro-pyridin-3-yl) -IS, 5S-3, 6-diazabicyclo [3.2.0] heptane (SOFINICLINE, ABT-894) and salts thereof are effective nicotinic receptor agonist compounds that demonstrated pharmacological effect for symptoms associated with attention-def icit/hyperactivity disorder.

Source: Patent EP2303272A1 – Sofinicline (abt-894 ) for attention-deficit/hyperactivity disorder – Google Patents
Video Search
[tubepress output=”searchInput” searchResultsUrl=”https://search.excitingads.com/searchresults/”]
[tubepress enableQuickplay=”true” theme=”tubepress/legacy-quickplay” mode=”tag” tagValue=”Hyperactivity” playerLocation=”popup” resultsPerPage=”10″ autoPlay=”false” thumbHeight=”514″ thumbWidth=”625″ responsiveEmbeds=”false” paginationBelow=”false”]
Video Search
[tubepress output=”searchInput” searchResultsUrl=”https://search.excitingads.com/searchresults/”]